Calcium-channel blocking agents, which include nifedipine, verapamil, and diltiazem, have recently been licensed for use in this country. Calcium antagonists are a heterogeneous group of agents with dissimilar structural, electrophysiologic, and pharmacologic properties. The chemical structures of the most commonly used calcium blocking agents (nifedipine, verapamil, and diltiazem) differ and the molecular basis of their […]

Continue reading " Canadian Health and Care Mall: Role of Calcium-Channel Blockers in Obstructive Airway Disease "